A hypothesis to account for the Mary Walker phenomenon.
Certain myasthenic patients show that their skeletal muscles produce a substance during ischemic exercise which, when released into the circulation, increases muscle weakness. This phenomenon has been named after Mary Walker, the physician who popularized its demonstration. It is suggested that ischemic exercise produces lactic acid that binds calcium, reducing ionized and total serum calcium. The decreased calcium has an adverse effect on skeletal muscle function especially in patients with myasthenia gravis, where neuromuscular function is often so precarious it may be interrupted by weak inhibitors.
D000109:Acetylcholine / Q000378:metabolism; D000200:Action Potentials; D004558:Electric Stimulation; D005071:Evoked Potentials; D005542:Forearm / Q000098:blood supply; D049673:History, 20th Century; D006801:Humans; D007511:Ischemia; D007773:Lactates / Q000097:blood / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000187:drug effects / Q000503:physiopathology; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000266:history / Q000503:physiopathology*; D009388:Neostigmine / Q000627:therapeutic use; D003473:Neuromuscular Nondepolarizing Agents / Q000097:blood*; D005082:Physical Exertion; D013997:Time Factors; D014459:Ulnar Nerve
D007773:Lactates; D003473:Neuromuscular Nondepolarizing Agents; D009388:Neostigmine; D000109:Acetylcholine